decisionhealth Newsletters, Part B News - 2007 Issue 9 (September)
ASP changes: B12 prices continue to fluctuate in latest price update; B12, potassium injections to see big ASP boosts
Subscribe or sign in to view the full article.
Article Overview
This article reviews a quarterly CMS average sales price update affecting Medicare Part B drugs. It highlights which injectable and oral drugs saw the largest payment changes, summarizes overall market-wide movement in the price list, and notes the additions to the quarterly ASP file. It is useful for coders, billers, and reimbursement staff tracking Part B drug payment changes and drug-code level updates.
Why This Topic Matters
Quarterly ASP changes can affect reimbursement for frequently billed drugs and injectables, so providers and billing teams need to monitor which codes are moving up or down and which new items were added to the list.
Article Sections
-
B12 and potassium injection payment changes
Discusses notable quarter-to-quarter payment movement for selected injectable drugs and places the changes in the context of prior ASP fluctuations.
-
Overall fourth quarter ASP list movement
Summarizes broader patterns across the quarterly ASP list, including how many items increased, decreased, or remained stable.
-
Key fourth quarter ASP changes for Part B drugs
Presents a table of the most notable payment increases and decreases among Part B drug codes for the quarter.
What You Will Learn
- How the quarterly CMS ASP update is described in the article
- Which categories of Part B drugs experienced the largest payment movement
- How the article frames the overall distribution of increases, decreases, and stable prices
- What types of drugs were newly added to the quarterly list
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Practice managers
- Reimbursement analysts
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com